TABLE 1.
Complex | Positions |
|||
---|---|---|---|---|
PVSP17B | PVSS12B | PVSS10E | PVSS7A | |
VHH, all ordered | 1–124 | 1–123 | 1–124 | 1–125 |
VHH coreb | 1–12 | 1–12 | 6–21 | 2–96 |
15–31 | 17–31 | 25–27 | ||
34–97 | 34–97 | 39–52 | ||
57–70 | ||||
72–97 | ||||
112–120 | 112–120 | 113–122 | ||
VP1, all ordered | 57–213 | 57–213 | 71–212 | 71–213 |
232–279 | 232–279 | 232–279 | 232–279 | |
VP1 core | 72–94 | 72–94 | 72–94 | 73–93 |
107–155 | 107–155 | 107–155 | 107–157 | |
172–174 | 172–174 | 172–174 | ||
177–180 | 177–180 | 177–180 | ||
183–209 | 183–209 | 183–209 | 183–213 | |
240–267 | 240–267 | 240–267 | 240–267 | |
272–279 | 272–279 | 272–279 | ||
VP2, all ordered | 1–43 | 1–43 | 1–42 | 10–43 |
53–159 | 53–159 | 55–159 | 53–159 | |
174–269 | 174–269 | 175–268 | 175–268 | |
VP2 core | 30–43 | 30–43 | 30–42 | 30–43 |
53–100 | 53–100 | 55–100 | 53–132 | |
102–133 | 102–133 | 102–132 | ||
143–159 | 143–159 | 144–159 | 143–159 | |
175–238 | 175–238 | 175–238 | 195–239 | |
250–259 | 250–259 | 250–259 | 247–260 | |
VP3, all ordered | 1–231 | 1–231 | 1–230 | 1–175 |
185–230 | ||||
VP3 core | 1–12c | 1–12c | 1–12c | 1–12c |
13–43c | 13–43c | 13–43c | 13–43c | |
44–70 | 44–70 | 44–70 | 44–71 | |
83–87 | 83–87 | 83–87 | ||
95–121 | 95–121 | 95–121 | ||
126–133 | 126–133 | 130–133 | 82–135 | |
142–177 | 142–177 | 142–172 | 143–147 | |
190–201 | 190–201 | 192–193 | 155–156 | |
206–225 | 206–225 | 206–225 | 188–226 |
Residues that were restrained to agree with main-chain coordinates from the structural homolog.
The amino acid residues correspond to the sequence of the antipoliovirus VHH.
N-terminal residues of VP3 are piecewise rigid bodies.